Apple Tree Partners Statement Regarding LP Litigation
Complaint filed by ATP May 30, 2025 against Rigmora Biotech Investor One LP and Rigmora Biotech Investor Two LP
On May 30, 2025, Apple Tree Partners (ATP)’s fund ATP Life Science Ventures initiated litigation by filing a Complaint against its controlling limited partners (LPs) Rigmora Biotech Investor One LP and Rigmora Biotech Investor Two LP. As reflected by the Complaint, the litigation seeks to compel these LPs to fulfill their contractual obligations according to the terms of the applicable Limited Partnership Agreement (LPA). ATP’s Complaint was filed in the Court of Chancery in the State of Delaware. The redacted public version, which details the specific ways in which Rigmora has failed to meet its capital commitments, may be viewed at atppdf.com.
ATP has delivered an industry-leading DPI of 1x on $2.5 billion. We take very seriously our mandate to deliver robust returns to our investors, and we take pride in our top-tier performance in life sciences venture capital, the integrity of our operations, and the substantial value of our current portfolio. We are fighting as hard as we can to ensure that our portfolio companies, and the innovations being propelled within them, can continue moving forward for the sake of stakeholders and patients.